Celgene to purchase Pharmion for $2.9 billion
Stephen McGuire
November 19 2007
Biotech company Celgene announced it has agreed to acquire blood cancer treatment maker Pharmion for $2.9 billion in cash and ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.